Interestingly, in line with our findings, pentraxin-3 has recently been suggested as a novel biomarker for RA diagnosis and a sensitive indicator of clinical arthritic activity in RA when compared to conventional diagnostic marker C-reactive protein (Qiu et al., 2021). Here, CRP is linked to rheumatoid arthritis.